283
Participants
Start Date
March 31, 2003
Primary Completion Date
September 30, 2006
Study Completion Date
August 31, 2007
Emtricitabine/tenofovir disoproxil fumarate
Lopinavir/ritonavir
Stavudine
Beth Israel Medical Center, New York
Columbia University, New York
Presbyterian Medical Center - University of PA, Philadelphia
University of Pennsylvania, Philadelphia, Philadelphia
University of Maryland, Institute of Human Virology, Baltimore
University of North Carolina, Chapel Hill
Duke University Medical Center, Durham
Emory University, Atlanta
Comprehensive Care Clinic, Nashville
Ohio State University, Columbus
Wishard Hospital, Indianapolis
Cook County Hospital Core Center, Chicago
University of California, San Diego Antiviral Rese, San Diego
San Francisco General Hospital, San Francisco
University of California, Davis Medical Center, Sacramento
University of Washington (Seattle), Seattle
San Mateo County AIDS Program, Stanford
Santa Clara Valley Medical Center, Stanford
Stanford Univ, Stanford
Willow Clinic, Stanford
Harbor General/UCLA, Torrance
University of Colorado Health Sciences Center, Denver, Denver
Univ of Miami, Miami
Northwestern University, Chicago
Methodist Hospital of Indiana, Indianapolis
Indiana University Hosp, Indianapolis
Johns Hopkins University, Baltimore
Harvard (Massachusetts General Hospital), Boston
Beth Israel Deaconess - West Campus, Boston
Brigham and Womens Hospital, Boston
Hennepin County Medical Clinic, Minneapolis
St. Louis Connect Care, St Louis
Washington University (St. Louis), St Louis
NYU/Bellevue, New York
Community Health Network, Inc., Rochester
University of Rochester Medical Center, Rochester
University of Cincinnati, Cincinnati
Case Western Reserve University, Cleveland
MetroHealth Medical Center, Cleveland
Rhode Island Hospital, Providence
The Miriam Hospital, Providence
University of Texas, Southwestern Medical Center, Dallas
Univ of Texas, Galveston, Galveston
University of Puerto Rico, San Juan
University of Witwatersrand, Parktown
National Institute of Allergy and Infectious Diseases (NIAID)
NIH